NCT00001144View on ClinicalTrials.gov

Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 1999

Study Completion Date

October 31, 2002

Conditions
Chronic Myeloid LeukemiaGraft vs Host Disease
Interventions
DRUG

Modified bone marrow stem cell transplantation

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001144 - Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter